| 2RA4 | B:3-66; B:3-66 | CRYSTAL STRUCTURE OF HUMAN MONOCYTE CHEMOATTRACTANT PROTEIN 4 (MCP-4/CCL13) |
| 2Q8R | H:1-63; H:1-63; H:1-63; H:1-63 | STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF CC CHEMOKINE CCL14 |
| 2Q8T | D:10-71; D:10-71; D:10-71; D:10-71 | CRYSTAL STRUCTURE OF THE CC CHEMOKINE CCL14 |
| 1NR2 | B:8-65; B:8-65 | HIGH RESOLUTION CRYSTAL STRUCTURES OF THYMUS AND ACTIVATION-REGULATED CHEMOKINE |
| 1NR4 | H:8-65; H:8-65; H:8-65; H:8-65; H:8-65; H:8-65; H:8-65; H:8-65 | HIGH RESOLUTION CRYSTAL STRUCTURES OF THYMUS AND ACTIVATION-REGULATED CHEMOKINE |
| 2JYO | A:1-63 | NMR SOLUTION STRUCTURE OF HUMAN MIP-3ALPHA/CCL20 |
| 1ML0 | D:8-67 | VIRAL CHEMOKINE BINDING PROTEIN M3 FROM MURINE GAMMAHERPESVIRUS68 IN COMPLEX WITH THE P8A VARIANT OF CC-CHEMOKINE MCP-1 |
| 2NZ1 | Y:8-67; Y:8-67; Y:8-67 | VIRAL CHEMOKINE BINDING PROTEIN M3 FROM MURINE GAMMAHERPESVIRUS68 IN COMPLEX WITH THE CC-CHEMOKINE CCL2/MCP-1 |
| 2X69 | E:4-66; E:4-66; E:4-66; E:4-66; E:4-66 | X-RAY STRUCTURE OF MACROPHAGE INFLAMMATORY PROTEIN-1 ALPHA POLYMER |
| 2X6G | R:6-66; R:6-66; R:6-66; R:6-66; R:6-66; R:6-66; R:6-66; R:6-66; R:6-66; R:6-66; R:6-66; R:6-66; R:6-66; R:6-66; R:6-66; R:6-66; R:6-66; R:6-66 | X-RAY STRUCTURE OF MACROPHAGE INFLAMMATORY PROTEIN-1 ALPHA (D27A) |
| 3KBX | E:4-66; E:4-66; E:4-66; E:4-66; E:4-66 | HUMAN MACROPHAGE INFLAMMATORY PROTEIN-1 ALPHA L3M_V63M |
| 1JE4 | A:3-66 | SOLUTION STRUCTURE OF THE MONOMERIC VARIANT OF THE CHEMOKINE MIP-1BETA |
| 2X6L | E:4-66; E:4-66; E:4-66; E:4-66; E:4-66 | X-RAY STRUCTURE OF MACROPHAGE INFLAMMATORY PROTEIN-1 BETA |
| 1RTN | B:3-65; B:3-65 | PROTON NMR ASSIGNMENTS AND SOLUTION CONFORMATION OF RANTES, A CHEMOKINE OF THE CC TYPE |
| 1RTO | B:3-65; B:3-65 | PROTON NMR ASSIGNMENTS AND SOLUTION CONFORMATION OF RANTES, A CHEMOKINE OF THE CC TYPE |
| 1U4L | B:4-65; B:4-65 | HUMAN RANTES COMPLEXED TO HEPARIN-DERIVED DISACCHARIDE I-S |
| 1U4M | B:4-65; B:4-65 | HUMAN RANTES COMPLEXED TO HEPARIN-DERIVED DISACCHARIDE III-S |
| 1U4R | D:3-65; D:3-65; D:3-65; D:3-65 | CRYSTAL STRUCTURE OF HUMAN RANTES MUTANT 44-AANA-47 |
| 2L9H | D:4-65; D:4-65; D:4-65; D:4-65 | OLIGOMERIC STRUCTURE OF THE CHEMOKINE CCL5/RANTES FROM NMR, MS, AND SAXS DATA |
| 2VXW | D:10-65; D:10-65; D:10-65; D:10-65 | STRUCTURAL AND FUNCTIONAL STUDIES OF THE POTENT ANTI-HIV CHEMOKINE VARIANT P2-RANTES |
| 1QNK | B:5-67; B:5-67 | TRUNCATED HUMAN GROB[5-73], NMR, 20 STRUCTURES |
| 1TVX | D:18-83; D:18-83; D:18-83; D:18-83 | NEUTROPHIL ACTIVATING PEPTIDE-2 VARIANT FORM M6L WITH FIVE ADDITIONAL AMINO TERMINAL RESIDUES (DSDLY) |
| 1LV9 | A:7-68 | CXCR3 BINDING CHEMOKINE IP-10/CXCL10 |
| 1O7Y | D:8-68; D:8-68; D:8-68; D:8-68 | CRYSTAL STRUCTURE OF IP-10 M-FORM |
| 1O7Z | B:9-64; B:9-64 | CRYSTAL STRUCTURE OF IP-10 T-FORM |
| 1O80 | B:2-68; B:2-68 | CRYSTAL STRUCTURE OF IP-10 H-FORM |
| 1RJT | A:3-68 | NMR STRUCTURE OF CXC CHEMOKINE CXCL11/ITAC |
| 1MGS | B:1-67; B:1-67 | THE SOLUTION STRUCTURE OF MELANOMA GROWTH STIMULATING ACTIVITY |
| 1MSG | B:1-67; B:1-67 | SOLUTION STRUCTURE OF GRO(SLASH)MELANOMA GROWTH STIMULATORY ACTIVITY DETERMINED BY 1H NMR SPECTROSCOPY |
| 1MSH | B:1-67; B:1-67 | SOLUTION STRUCTURE OF GRO(SLASH)MELANOMA GROWTH STIMULATORY ACTIVITY DETERMINED BY 1H NMR SPECTROSCOPY |
| 1ROD | B:31-66; B:31-66; B:1-30; B:1-30 | CHIMERIC PROTEIN OF INTERLEUKIN 8 AND HUMAN MELANOMA GROWTH STIMULATING ACTIVITY PROTEIN, NMR |
| 1QE6 | D:1-66; D:1-66; D:1-66; D:1-66 | INTERLEUKIN-8 WITH AN ADDED DISULFIDE BETWEEN RESIDUES 5 AND 33 (L5C/H33C) |
| 1PFM | D:12-67; D:12-67; D:12-67; D:12-67 | PF4-M2 CHIMERIC MUTANT WITH THE FIRST 10 N-TERMINAL RESIDUES OF R-PF4 REPLACED BY THE N-TERMINAL RESIDUES OF THE IL8 SEQUENCE. MODELS 1-15 OF A 27-MODEL SET. |
| 1PFN | D:12-67; D:12-67; D:12-67; D:12-67 | PF4-M2 CHIMERIC MUTANT WITH THE FIRST 10 N-TERMINAL RESIDUES OF R-PF4 REPLACED BY THE N-TERMINAL RESIDUES OF THE IL8 SEQUENCE. MODELS 16-27 OF A 27-MODEL SET. |
| 1RHP | D:7-67; D:7-67; D:7-67; D:7-67 | CRYSTAL STRUCTURE OF RECOMBINANT HUMAN PLATELET FACTOR 4 |
| 1QG7 | B:3-66; B:3-66 | STROMA CELL-DERIVED FACTOR-1ALPHA (SDF-1ALPHA) |
| 1SDF | A:3-66 | SOLUTION STRUCTURE OF STROMAL CELL-DERIVED FACTOR-1 (SDF-1), NMR, MINIMIZED AVERAGE STRUCTURE |
| 1VMC | A:8-66 | STROMA CELL-DERIVED FACTOR-1ALPHA (SDF-1ALPHA) |
| 2K01 | C:203-266; C:203-266 | STRUCTURE OF A LOCKED SDF1 DIMER |
| 2K03 | C:203-266; C:203-266 | STRUCTURE OF SDF1 IN COMPLEX WITH THE CXCR4 N-TERMINUS CONTAINING A SULFOTYROSINE AT POSTITION 21 |
| 2K04 | C:203-266; C:203-266 | STRUCTURE OF SDF1 IN COMPLEX WITH THE CXCR4 N-TERMINUS CONTAINING NO SULFOTYROSINES |
| 2K05 | C:203-266; C:203-266 | STRUCTURE OF SDF1 IN COMPLEX WITH THE CXCR4 N-TERMINUS CONTAINING SULFOTYROSINES AT POSTITIONS 7, 12 AND 21 |
| 2KEC | A:3-66 | STRUCTURE OF SDF-1/CXCL12 |
| 2KED | A:3-66 | STRUCTURE OF SDF-1/CXCL12 |
| 2KEE | A:3-66 | STRUCTURE OF SDF-1/CXCL12 |
| 2KOL | A:3-66 | SOLUTION STRUCTURE OF HUMAN SDF1-ALPHA H25R |
| 2NWG | B:4-66; B:4-66 | STRUCTURE OF CXCL12:HEPARIN DISACCHARIDE COMPLEX |
| 2SDF | A:3-66 | SOLUTION NMR STRUCTURE OF STROMAL CELL-DERIVED FACTOR-1 (SDF-1), 30 STRUCTURES |
| 2JP1 | B:2-60; B:2-60 | SOLUTION STRUCTURE OF THE ALTERNATIVE CONFORMATION OF XCL1/LYMPHOTACTIN |
)
)